Reliability and validity of Chinese version of Fear of Progression Questionnaire-Short Form for caregivers of melanoma patients_West China Medical Journal

Authors：

PENG Hu , YANG Keyi ,  DENG Yaotiao

Department of Head & Neck Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

DENG Yaotiao, Email: dengyaotiao@163.com

Keywords：

Melanoma; Caregiver; Fear of Progression Questionnaire-Short Form; Validity; Reliability

DOI：

10.7507/1002-0179.202101167

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To formulate the Chinese version of Fear of Progression Questionnaire-Short Form/Caregiver Version (FoP-Q-SF/C) and examine the reliability and validity of the scale.Methods A questionnaire survey of FoP-Q-SF/C was conducted among the caregivers of melanoma out-patients in West China Hospital of Sichuan University from June 2019 to March 2020. Convenient sampling method was adopted. The validity and reliability of the scale were analyzed.Results A total of 247 caregivers of melanoma out-patients were investigated by the FoP-Q-SF/C, and 101 valid questionnaires were finally collected. The Cronbach’s α of the FoP-Q-SF/C scale was 0.919, and the Guttman Split-Half coefficient was 0.906. Using exploratory factor analysis to extract 3 common factors, the cumulative explainable total variation was 73.964%. The model fit was as follows: chi-square/degree of freedom was 1.950, standardized root mean square residual was 0.067, goodness of fit index was 0.859, incremental fit index was 0.939, comparative fit index was 0.938, Tucker-Lewis index or non-normed fit index was 0.918, and the root-mean-square error of approximation was 0.097.Conclusions The FoP-Q-SF/C scale formulated in this study is divided into three dimensions, which has good reliability and validity, meanwhile, it is relatively simple and can be used to clinically screen melanoma caregivers’ FoP-Q-SF/C levels. However, the application of this scale in other diseases still needs further testing.

Citation： PENG Hu, YANG Keyi, DENG Yaotiao. Reliability and validity of Chinese version of Fear of Progression Questionnaire-Short Form for caregivers of melanoma patients. West China Medical Journal, 2021, 36(7): 900-906. doi: 10.7507/1002-0179.202101167 Copy

1.	Wu Y, Wang Y, Wang L, et al. Burden of melanoma in China, 1990-2017: findings from the 2017 global burden of disease study. Int J Cancer, 2020, 147(3): 692-701.
2.	Lu D, Andersson TM, Fall K, et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. JAMA Oncol, 2016, 2(9): 1188-1196.
3.	Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol, 2000, 18(4): 893-903.
4.	McFarland DC, Shaffer KM, Tiersten A, et al. Physical symptom burden and its association with distress, anxiety, and depression in breast cancer. Psychosomatics, 2018, 59(5): 464-471.
5.	McFarland DC, Shaffer KM, Polizzi H, et al. Associations of physical and psychologic symptom burden in patients with philadelphia chromosome-negative myeloproliferative neoplasms. Psychosomatics, 2018, 59(5): 472-480.
6.	Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology, 2013, 22(1): 1-11.
7.	Hodges LJ, Humphris GM. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology, 2009, 18(8): 841-848.
8.	Mellon S, Kershaw TS, Northouse LL, et al. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psychooncology, 2007, 16(3): 214-223.
9.	Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer, 2009, 17(3): 241-251.
10.	Park B, Kim SY, Shin JY, et al. Prevalence and predictors of anxiety and depression among family caregivers of cancer patients: a nationwide survey of patient-family caregiver dyads in Korea. Support Care Cancer, 2013, 21(10): 2799-2807.
11.	National cancer institute. NCI dictionary of cancer terms. (2018-04-05)[2021-01-03]. https://www.cancer.gov/publications/dictionaries/cancer-terms.
12.	Zimmermann T, Herschbach P, Wessarges M, et al. Fear of progression in partners of chronically ill patients. Behav Med, 2011, 37(3): 95-104.
13.	Clever K, Schepper F, Pletschko T, et al. Psychometric properties of the fear of progression questionnaire for parents of children with cancer (FoP-Q-SF/PR). J Psychosom Res, 2018, 107: 7-13.
14.	Lin CR, Chen SC, Chang JT, et al. Fear of cancer recurrence and its impacts on quality of life in family caregivers of patients with head and neck cancers. J Nurs Res, 2016, 24(3): 240-248.
15.	吴奇云. 原发性肝癌患者及其配偶对疾病进展恐惧的现状调查及研究. 上海: 第二军医大学, 2016.
16.	Clever K, Schepper F, Küpper L, et al. Fear of progression in parents of children with cancer: results of an online expert survey in pediatric oncology. Klin Padiatr, 2018, 230(3): 130-137.
17.	Mehnert A, Herschbach P, Berg P, et al. Fear of progression in breast cancer patients--validation of the short form of the fear of progression questionnaire (FoP-Q-SF). Z Psychosom Med Psychother, 2006, 52(3): 274-288.
18.	吴奇云, 叶志霞, 李丽, 等. 癌症患者恐惧疾病进展简化量表的汉化及信效度分析. 中华护理杂志, 2015, 50(12): 1515-1519.
19.	Mahendran R, Liu J, Kuparasundram S, et al. Validation of the English and simplified mandarin versions of the fear of progression questionnaire-short form in Chinese cancer survivors. BMC Psychol, 2020, 8(1): 10.
20.	翟本瑞. 影响电子邮寄问卷回收率因素之研究. 兰州大学学报(社会科学版), 2008, 36(1): 44-59.

1. Wu Y, Wang Y, Wang L, et al. Burden of melanoma in China, 1990-2017: findings from the 2017 global burden of disease study. Int J Cancer, 2020, 147(3): 692-701.
2. Lu D, Andersson TM, Fall K, et al. Clinical diagnosis of mental disorders immediately before and after cancer diagnosis: a nationwide matched cohort study in Sweden. JAMA Oncol, 2016, 2(9): 1188-1196.
3. Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol, 2000, 18(4): 893-903.
4. McFarland DC, Shaffer KM, Tiersten A, et al. Physical symptom burden and its association with distress, anxiety, and depression in breast cancer. Psychosomatics, 2018, 59(5): 464-471.
5. McFarland DC, Shaffer KM, Polizzi H, et al. Associations of physical and psychologic symptom burden in patients with philadelphia chromosome-negative myeloproliferative neoplasms. Psychosomatics, 2018, 59(5): 472-480.
6. Koch L, Jansen L, Brenner H, et al. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology, 2013, 22(1): 1-11.
7. Hodges LJ, Humphris GM. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psychooncology, 2009, 18(8): 841-848.
8. Mellon S, Kershaw TS, Northouse LL, et al. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psychooncology, 2007, 16(3): 214-223.
9. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer, 2009, 17(3): 241-251.
10. Park B, Kim SY, Shin JY, et al. Prevalence and predictors of anxiety and depression among family caregivers of cancer patients: a nationwide survey of patient-family caregiver dyads in Korea. Support Care Cancer, 2013, 21(10): 2799-2807.
11. National cancer institute. NCI dictionary of cancer terms. (2018-04-05)[2021-01-03]. https://www.cancer.gov/publications/dictionaries/cancer-terms.
12. Zimmermann T, Herschbach P, Wessarges M, et al. Fear of progression in partners of chronically ill patients. Behav Med, 2011, 37(3): 95-104.
13. Clever K, Schepper F, Pletschko T, et al. Psychometric properties of the fear of progression questionnaire for parents of children with cancer (FoP-Q-SF/PR). J Psychosom Res, 2018, 107: 7-13.
14. Lin CR, Chen SC, Chang JT, et al. Fear of cancer recurrence and its impacts on quality of life in family caregivers of patients with head and neck cancers. J Nurs Res, 2016, 24(3): 240-248.
15. 吴奇云. 原发性肝癌患者及其配偶对疾病进展恐惧的现状调查及研究. 上海: 第二军医大学, 2016.
16. Clever K, Schepper F, Küpper L, et al. Fear of progression in parents of children with cancer: results of an online expert survey in pediatric oncology. Klin Padiatr, 2018, 230(3): 130-137.
17. Mehnert A, Herschbach P, Berg P, et al. Fear of progression in breast cancer patients--validation of the short form of the fear of progression questionnaire (FoP-Q-SF). Z Psychosom Med Psychother, 2006, 52(3): 274-288.
18. 吴奇云, 叶志霞, 李丽, 等. 癌症患者恐惧疾病进展简化量表的汉化及信效度分析. 中华护理杂志, 2015, 50(12): 1515-1519.
19. Mahendran R, Liu J, Kuparasundram S, et al. Validation of the English and simplified mandarin versions of the fear of progression questionnaire-short form in Chinese cancer survivors. BMC Psychol, 2020, 8(1): 10.
20. 翟本瑞. 影响电子邮寄问卷回收率因素之研究. 兰州大学学报(社会科学版), 2008, 36(1): 44-59.

West China Medical Journal

Reliability and validity of Chinese version of Fear of Progression Questionnaire-Short Form for caregivers of melanoma patients

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content